Skip to main content
SpringerLink
Log in

Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics

  • Conference paper
  • First Online:
Oncogenes Meet Metabolism

Part of the book series: Ernst Schering Foundation Symposium Proceedings ((SCHERING FOUND,volume 2007/4))

Abstract

There exists at present an urgent desire for better biomarkers, especially in the context of pharmaceutical drug development and in the detection and management of disease. Many researchers in the area of biomarker discovery and development have turned to the “-omics” sciences as a way of addressing these needs. Metabolic profiling, or metabonomics, defines the metabolic phenotype and offers a source of novel biomarkers that have better potential to translate effectively. This review will discuss the broad philosophy and motivations behind metabonomics, and illustrate the case with applications relevant to pharmaceutical development and patient management. Particular focus will be paid to the potential of metabonomics to contribute to biomarker discovery in toxicology and cancer research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Saffar NMS, Troy H, Ramirez de Molina A et al. (2006) Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res 66:427–434

    Article  CAS  PubMed  Google Scholar 

  • Anthony ML, Sweatman BC, Beddell CR et al. (1994) Pattern-recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear-magnetic-resonance spectra of urine. Mol Pharmacol 46:199–211

    CAS  PubMed  Google Scholar 

  • Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23:17–28

    CAS  PubMed  Google Scholar 

  • Baggerly KA, Morris JS, Edmonson SR et al. (2005) Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst 97:307–309

    Article  CAS  PubMed  Google Scholar 

  • Beger RD, Schnackenberg LK et al. (2006) Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics 2:125–134

    Article  CAS  Google Scholar 

  • Brindle JT, Antti H, Holmes E et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using H-1-NMR-based metabonomics. Nat Med 8:1439–1444

    Article  CAS  PubMed  Google Scholar 

  • Bundy JG, Iyer NG, Gentile MS et al. (2006) Metabolic consequences of p300 gene deletion in human colon cancer cells. Cancer Res 66:7606–7614

    Article  CAS  PubMed  Google Scholar 

  • Cheng LL, Burns MA, Taylor JL et al. (2005) Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65:3030–3034

    CAS  PubMed  Google Scholar 

  • Clayton TA, Lindon JC, Cloarec O et al. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073–1077

    Article  CAS  PubMed  Google Scholar 

  • Coen M, Hong YS, Clayton TA et al. (2007) The mechanism of galactosamine toxicity revisited: a metabonomic study. J Proteome Res 6:2711–2719

    Article  CAS  PubMed  Google Scholar 

  • Connor SC, Hodson MP, Ringeissen S et al. (2004a) Development of a multivariate statistical model to predict peroxisome proliferation in the rat, based on urinary H-1-NMR spectral patterns. Biomarkers 9:364–385

    Article  CAS  PubMed  Google Scholar 

  • Connor SC, Wu W, Sweatman BC et al. (2004b) Effects of feeding and body weight loss on the H-1-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers 9:156–179

    Article  CAS  PubMed  Google Scholar 

  • Denkert C, Budczies J, Kind T et al. (2006) Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res 66:10795–10804

    Article  CAS  PubMed  Google Scholar 

  • Dieterle F, Schlotterbeck GT, Ross A et al. (2006) Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. Chem Res Toxicol 19:1175–1181

    Article  CAS  PubMed  Google Scholar 

  • Dumas ME, Wilder SP, Bihoreau MT et al. (2007) Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet 39:666–672

    Article  CAS  PubMed  Google Scholar 

  • Ebbels T, Keun H et al. (2003) Toxicity classification from metabonomic data using a density superposition approach: `CLOUDS'. Anal Chim Acta 490:109–122

    Article  CAS  Google Scholar 

  • Ebbels TMD, Keun HC, Beckonert OP et al. (2007) Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the Consortium on Metabonomic Toxicology screening approach. J Proteome Res 6:4407–4422

    CAS  Google Scholar 

  • Fossel ET, Carr JM, McDonagh J (1986) Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 315:1369–1376

    CAS  Google Scholar 

  • Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2:566–580

    Article  CAS  PubMed  Google Scholar 

  • Fricke ST, Rodriguez O, Vanmeter J et al. (2006) In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate 66:708–717

    Article  CAS  PubMed  Google Scholar 

  • Gartland KPR, Anthony ML, Beddell CR et al. (1990) Proton Nmr-studies on the effects of uranyl-nitrate on the biochemical-composition of rat urine and plasma. J Pharmaceut Biomed Anal 8:951–954

    Article  CAS  Google Scholar 

  • Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899

    Article  CAS  PubMed  Google Scholar 

  • Glunde K, Jie C, Bhujwall ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64:4270–4276

    Article  CAS  PubMed  Google Scholar 

  • Glunde K, Raman V, Mori N et al. (2005) RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 65:11034–11043

    Article  CAS  PubMed  Google Scholar 

  • Glunde K, Jacobs MA, Bhujwall ZM (2006) Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 6:821–829

    Article  CAS  PubMed  Google Scholar 

  • Gooderham NJ, Lauber SN, Lauber SN et al. (2006) Mechanisms of action of carcinogenic heterocyclic amines. Toxicol Lett 164:S61–S62

    Article  Google Scholar 

  • Holmes E, Bonner FW, Sweatman BC et al. (1992) Nuclear-magnetic-resonance spectroscopy and pattern-recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(Ii) chloride and 2-bromoethanamine. Mol Pharmacol 42:922–930

    CAS  PubMed  Google Scholar 

  • Holmes E, Tsang TM, Huang JT et al. (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. Plos Medicine 3:e327

    Article  PubMed  Google Scholar 

  • Iorio E, Mezzanzanica D, Alberti P et al. (2005) Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 65:9369–9376

    Article  CAS  PubMed  Google Scholar 

  • Ito S, Ohga T, Saeki H et al. (2005) p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Int J Cancer 113:22–28

    Article  CAS  PubMed  Google Scholar 

  • Katz-Brull R, Lavin PT, Lenkinski RE (2002) Clinical utility of proton MRS in characterizing breast lesions. Radiology 225:650–651

    Google Scholar 

  • Keun HC (2006) Metabonomic modeling of drug toxicity. Pharmacol Ther 109:92–106

    Article  CAS  PubMed  Google Scholar 

  • Keun HC, Athersuch TJ (2007) Application of metabonomics in drug development. Pharmacogenomics 8:731–741

    Article  CAS  PubMed  Google Scholar 

  • Keun HC, Ebbels TMD et al. (2002) Analytical reproducibility in H-1 NMR-based metabonomic urinalysis. Chem Res Toxicol 15:1380–1386

    Article  CAS  PubMed  Google Scholar 

  • Keun HC, Ebbels TMD et al. (2004) Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem Res Toxicol 17:579–587

    Article  CAS  PubMed  Google Scholar 

  • Lindon JC, Nicholson JK, Holmes E et al. (2003) Contemporary issues in toxicology – the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187:137–146

    Article  CAS  PubMed  Google Scholar 

  • Lindon JC, Keun HC, Ebbels TM et al (2005) The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6:691–699

    Article  CAS  PubMed  Google Scholar 

  • Makinen VP, Soininen P et al. (2007) Cardiovascular risk factors in type 1 diabetes: a metabonomic study by 1H NMR spectroscopy of serum. Atherosclerosis Suppl 8:218–218

    Article  Google Scholar 

  • Matoba S, Kang JG, Patino WD et al. (2006) p53 regulates mitochondrial respiration. Science 312:1650–1653

    Article  CAS  PubMed  Google Scholar 

  • Mortishire-Smith RJ, Skiles GL, Lawrence JW et al. (2004) Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem Res Toxicol 17:165–173

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Lindon JC, Holmes E (1999) `Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Connelly J, Lindon JC et al. (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Holmes E, Lindon JC et al. (2004) The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22:1268–1274

    Article  CAS  PubMed  Google Scholar 

  • Nicholson JK, Holmes E, Lindon JC et al. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3:431–438

    Article  CAS  PubMed  Google Scholar 

  • Odunsi K, Wollman RM, Ambroson CB et al. (2005) Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int J Cancer 113:782–788

    Article  CAS  PubMed  Google Scholar 

  • Okunieff P, Zietman A, Kahn J et al (1990) Lack of efficacy of water-suppressed proton nuclear-magnetic-resonance spectroscopy of plasma for the detection of malignant tumors. N Engl J Med 322:953–958

    Article  CAS  PubMed  Google Scholar 

  • Petricoin EF, Ardekani AM, Hitt BA et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572–577

    Article  CAS  PubMed  Google Scholar 

  • Pollard PJ, Briere JJ, Alam NA et al. (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1 alpha in tumours which result from germline FH, SDH mutations. Human Molr Genet 14:2231–2239

    Article  CAS  Google Scholar 

  • Raamsdonk LM, Teusink B, Broadhurst D et al. (2001) A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19:45–50

    Article  CAS  PubMed  Google Scholar 

  • Ransohoff DF (2005) Opinion – bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5:142–149

    Article  CAS  PubMed  Google Scholar 

  • Ratnam S, Kent C (1995) Early increase in choline kinase-activity upon induction of the H-Ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys 323:313–322

    Article  CAS  PubMed  Google Scholar 

  • Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809–822

    Article  CAS  PubMed  Google Scholar 

  • Robertson DG, Reily MD, Sigler RE et al. (2000) Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57:326–337

    Article  CAS  PubMed  Google Scholar 

  • Sanins SM, Nicholson JK, Elcombe C et al. (1990) Hepatotoxin-induced hypertaurinuria – a proton Nmr study. Arch Toxicol 64:407–411

    Article  CAS  PubMed  Google Scholar 

  • Tate AR, Underwood J, Acosta DM et al. (2006) Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. Nmr Biomed 19:411–434

    Article  CAS  PubMed  Google Scholar 

  • Teahan O, Gamble S, Holmes E et al. (2006) Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 78:4307–4318

    Article  CAS  PubMed  Google Scholar 

  • Teichert F, Verschoyle RD et al. (2008) Metabolic Profiling of Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) tissue by 1H-NMR analysis – evidence for unusual phospholipid metabolism. Prostate

    Google Scholar 

  • Tsang TA, Woodman B et al. (2006) Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS H-1 NMR spectroscopy. J Proteome Res 5:483–492

    Article  CAS  PubMed  Google Scholar 

  • Tweeddale H, Notley-McRobb L, Ferenci T (1999) Assessing the effect of reactive oxygen species on Escherichia coli using a metabolome approach. Redox Rep 4:237–241

    Article  CAS  PubMed  Google Scholar 

  • Ushijima T (2007) Epigenetic field for cancerization. J Biochem Mol Biol 40:142–150

    CAS  PubMed  Google Scholar 

  • Vineis P, Perera F (2007) Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 16:1954–1965

    Article  CAS  PubMed  Google Scholar 

  • Wang YL, Utzinger J, Xiao SH et al. (2006) System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol Biochem Parasitol 146:1–9

    Article  CAS  PubMed  Google Scholar 

  • Waters NJ, Waterfield CJ, Farrant RD et al. (2006) Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J Proteome Res 5:1448–1459

    Article  CAS  PubMed  Google Scholar 

  • Wevers RA, Engelke UFH et al. (1999) H-1-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem 45:539–548

    CAS  PubMed  Google Scholar 

  • Wheatley DN (2005) Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells. Semin Cancer Biol 15:247–253

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

I would like to thank Mr. Danny Yakoub and Dr. Mary Bollard for their help in the production of the figures, and Miss Alexandra Backshall for proof-reading the manuscript.

Author information

Authors and Affiliations

  1. Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Imperial College Faculty of Medicine, Sir Alexander Fleming Building, Exhibition Road, South Kensington, London, SW7 2AZ, UK

    H. C. Keun

Authors
  1. H. C. Keun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. C. Keun .

Editor information

G. Kroemer D. Mumberg H. Keun B. Riefke T. Steger-Hartmann K. Petersen

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Keun, H.C. (2008). Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics. In: Kroemer, G., Mumberg, D., Keun, H., Riefke, B., Steger-Hartmann, ., Petersen, K. (eds) Oncogenes Meet Metabolism. Ernst Schering Foundation Symposium Proceedings, vol 2007/4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2008_090

Download citation

  • DOI: https://doi.org/10.1007/2789_2008_090

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79477-6

  • Online ISBN: 978-3-540-79478-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation